Skip to main content
OpenTrials
Completed

NCT Number: NCT01901991

Localization of Nonpalpable Breast Lesions

Each year the Danish mammography-screening programme identifies a large number of patients with small non-palpable breast cancers or precancerous lesions. The majority of these patients are suitable for breast conserving surgery (BCS). The object of BCS is to remove the suspicious lesion completely without removing excess healthy breast tissue. To obtain this accurate lesion localization is essential.

Until today the standard procedure in Denmark has been wire guided localization (WGL). Although the method has been utilized for a number of years it has several disadvantages. Often inaccurate lesion localization leads to incomplete lesion removal (positive margin) and subsequently reoperation. It can postpone the additional systemic treatment, offered after the operation. Other disadvantages are poor cosmetic outcome and inconvenient planning for the patient and the departments involved. The wire needs to be placed on the day of the operation, which decreases the flexibility of the procedure.

The purpose of this study is to test a new method named radioactive seed localization (RSL). The method uses a small titanium seed containing radioactive iodine. It will be placed in the centre of the lesion, and during the operation, the surgeon can locate it with a handheld gamma probe. The seed can be placed a few days in advance, which means a more flexible course of treatment. The method seems promising with regards to reoperation rates, but it needs further testing.

Hypothesis:

RSL is a more accurate method, for localization of nonpalpable breast lesions, than WGL. Using RSL obtains, to a great extent, adequate negative margins, resulting in a reduced number of re-operations.

The study will be performed as a randomised clinical trial, where the two methods will be compared to each other. The trial will be performed at the department of breast surgery at Rigshospitalet and include patients with nonpalpable breast lesions. Besides reoperation rates, duration of the surgical procedure and the amount of removed breast tissue will be compared.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

Female

Study type

Interventional

Phase

Not applicable

Primary location

Rigshospitalet (Copenhagen University Hospital)

Copenhagen, Østerbro, 2100, Denmark

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients with nonpalpable breast lesions, carcinoma in situ or invasive carcinoma, where preoperative lesion localization is necessary.
  • All age groups, minimum 18 years

Exclusion criteria

  • Patients with benign nonpalpable breast lesions.
  • Patients who are unable to comprehend the information.
  • Patients who are pregnant, breastfeeding or have children < 3 years.
  • Patients who have lesions, which requires more than two wires or seeds for localization.

Treatment and study plan

Radioactive seed localization (RSL)

Procedure

Localization of nonpalpable breast lesions with Radioactive seed localization

Wire-guided localization (WGL)

Procedure

Localization of nonpalpable breast lesions with Wire-guided localization

Primary outcomes

  1. Re-operation rate due to positive microscopic margins detected at the final pathological evaluation.

    Time frame: Re-operation within 3 months after the initial breast conserving surgery.

Secondary outcomes

  1. Amount of excised breast tissue in relation to tumour size.

    Time frame: 3 months.

Other outcomes

  1. Duration of the surgical procedure.

    Time frame: 3 months.

Sponsors and collaborators

Lead sponsor

Rigshospitalet, Denmark

Other

Registry information

Official study title

A Randomized Study of Localization of Nonpalpable Breast Lesions - RSL vs WGL

Important dates

Study start
2014
Primary completion
2016
Study completion
2016
First posted
Jul 17, 2013
Registry last updated
Aug 11, 2017

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.